Immediate-release oral oxycodone regulatory update

FDA’s Anesthetic and Analgesic Drug Products and Drug Safety and Risk Management advisory committees will hold a joint meeting on April 5 to discuss an NDA from Inspirion for abuse-deterrent, immediat...